News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Casdin Capital, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/10/2023 |
SC 13G/A
| Casdin Capital, LLC reports a 9% stake in MaxCyte, Inc. |
| 02/14/2022 |
SC 13G/A
| Casdin Capital, LLC reports a 6.5% stake in Verve Therapeutics, Inc. |
| 02/11/2022 |
SC 13G/A
| Casdin Capital, LLC reports a 6.6% stake in Magenta Therapeutics, Inc. |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2022 |
SC 13G/A
| Casdin Capital, LLC reports a 5.4% stake in Invitae Corporation |
| 02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2021 |
SC 13G/A
| Casdin Capital, LLC reports a 6.4% stake in Invitae Corporation |
| 02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/06/2020 |
SC 13G/A
| Casdin Capital, LLC reports a 12.1% stake in BioLife Solutions, Inc. |
| 02/06/2020 |
SC 13G/A
| Casdin Capital, LLC reports a 7.9% stake in Magenta Therapeutics, Inc. |
| 02/06/2020 |
SC 13G/A
| Casdin Capital, LLC reports a 6% stake in Gritstone Oncology, Inc. |
| 02/06/2020 |
SC 13G/A
| Casdin Capital, LLC reports a 2.9% stake in Constellation Pharmaceuticals, Inc. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Casdin Capital, LLC reports a 8% stake in Magenta Therapeutics, Inc. |
| 08/15/2018 |
SC 13G/A
| Casdin Capital, LLC reports a 14.8% stake in BioLife Solutions, Inc. |
|
|